ocaratuzumab - CISMeF

Preferred Label : ocaratuzumab;

MeSH note : an anti-CD20 antibody for treatment of cancer in phase I/II clinical trials (2010);

CISMeF synonym : LY 2469298; AME 133;

MeSH hyponym : LY2469298; LY-2469298; AME133; AME-133V; AME-133;

Is substance : O;

UNII : NTY9893GD0;

Détails

Origin ID

C550337;

UMLS CUI

C0796614;

Currated CISMeF NLP mapping
- Ocaratuzumab [NCIt concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
- antibodies, monoclonal, humanized [MeSH Descriptor]
Record concept(s)
- AME 133 [MeSH concept]
- LY 2469298 [MeSH concept]
- ocaratuzumab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Ocaratuzumab [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients